Premature placental aging in term small-for-gestational-age and growth-restricted fetuses

Objective To perform a comprehensive assessment of the placental aging process in small term fetuses classified as being small-for-gestational age (SGA) or having fetal growth restriction (FGR) through analysis of senescence and apoptosis markers. Methods This was a prospective nested case-control s...

Descripción completa

Detalles Bibliográficos
Autores: Paules C, Dantas AP, Miranda J, Crovetto F, Eixarch E, Rodriguez-Sureda V, Dominguez C, Casu G, Rovira C, Nadal A, Crispi F, Gratacos E
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Institución:Fundació Sant Joan de Déu
Repositorio:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
OAI Identifier:oai:fsjd.fundanetsuite.com:p14796
Acceso en línea:https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14796
Access Level:acceso abierto
Palabra clave:aging
apoptosis
fetal growth restriction
placenta
senescence
small-for-gestational age
id ES_1ff130bc6ef780bef68b52bf4b3cfef0
oai_identifier_str oai:fsjd.fundanetsuite.com:p14796
network_acronym_str ES
network_name_str España
repository_id_str
spelling Premature placental aging in term small-for-gestational-age and growth-restricted fetusesPaules CDantas APMiranda JCrovetto FEixarch ERodriguez-Sureda VDominguez CCasu GRovira CNadal ACrispi FGratacos Eagingapoptosisfetal growth restrictionplacentasenescencesmall-for-gestational ageObjective To perform a comprehensive assessment of the placental aging process in small term fetuses classified as being small-for-gestational age (SGA) or having fetal growth restriction (FGR) through analysis of senescence and apoptosis markers. Methods This was a prospective nested case-control study of singleton pregnancies delivered at term, including 21 control pregnancies with normally grown fetuses and 36 with a small fetus classified as SGA (birth weight between the 3rd and 9th percentiles and normal fetoplacental Doppler; n=18) or FGR (birth weight <3rd percentile and/or abnormal cerebroplacental ratio and/or uterine artery Doppler; n=18). Telomerase activity, telomere length (quantified by comparing the amount of amplification product for the telomere sequence (T) to that of a single copy of the gene 36B4 (S)) and RNA expression of senescence (Sirtuins 1, 3 and 6) and apoptosis (p53, p21, BAX and Caspases 3 and 9) markers (analyzed using the 2(-Delta Delta Ct) method) were determined in placental samples collected at birth and compared between the three groups. Results Compared to pregnancies with a normally grown fetus, both SGA and FGR pregnancies presented signs of accelerated placental aging, including lower telomerase activity (mean +/- SD, 12.8 +/- 6.6% in controls vs 7.98 +/- 4.2% in SGA vs 7.79 +/- 4.6% in FGR; P=0.008), shorter telomeres (mean +/- SD T/S ratio, 1.20 +/- 0.6 in controls vs 1.08 +/- 0.9 in SGA vs 0.66 +/- 0.5 in FGR; P=0.047) and reduced Sirtuin-1 RNAexpression (mean +/- SD 2(-Delta Delta Ct), 1.55 +/- 0.8 in controls vs 0.91 +/- 0.8 in SGA vs 0.63 +/- 0.5 in FGR; P=0.001) together with increased p53 RNA expression (median (interquartile range) 2(-Delta Delta Ct), 1.07 (0.3-3.3) in controls vs 5.39 (0.6-15) in SGA vs 3.75 (0.9-7.8) in FGR; P=0.040). FGR cases presented signs of apoptosis, with increased Caspase-3 RNA levels (median (interquartile range) 2(-Delta Delta Ct), 0.94 (0.7-1.7) in controls vs 3.98 (0.9-31) in FGR; P=0.031) and Caspase-9 RNA levels (median (interquartile range) 2(-Delta Delta Ct), 1.21 (0.6-4.0) in controls vs 3.87 (1.5-9.0) in FGR; P= 0.037) compared with controls. In addition, Sirtuin-1 RNA expression, telomerase activity, telomere length and Caspase-3 activity showed significant linear trends across groups as severity of the condition increased. Conclusions Accelerated placental aging was observed in both clinical forms of late-onset fetal smallness (SGA and FGR), supporting a common pathophysiology and challenging the concept of SGA fetuses being constitutionally small. Copyright (c) 2018 ISUOG. Published by John Wiley & Sons Ltd.WILEY2019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttps://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14796ULTRASOUND IN OBSTETRICS & GYNECOLOGYISSN: 09607692ISSNe: 14690705reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déuinstname:Fundació Sant Joan de DéuInglésinfo:eu-repo/semantics/openAccessoai:fsjd.fundanetsuite.com:p147962026-05-27T12:37:41Z
dc.title.none.fl_str_mv Premature placental aging in term small-for-gestational-age and growth-restricted fetuses
title Premature placental aging in term small-for-gestational-age and growth-restricted fetuses
spellingShingle Premature placental aging in term small-for-gestational-age and growth-restricted fetuses
Paules C
aging
apoptosis
fetal growth restriction
placenta
senescence
small-for-gestational age
title_short Premature placental aging in term small-for-gestational-age and growth-restricted fetuses
title_full Premature placental aging in term small-for-gestational-age and growth-restricted fetuses
title_fullStr Premature placental aging in term small-for-gestational-age and growth-restricted fetuses
title_full_unstemmed Premature placental aging in term small-for-gestational-age and growth-restricted fetuses
title_sort Premature placental aging in term small-for-gestational-age and growth-restricted fetuses
dc.creator.none.fl_str_mv Paules C
Dantas AP
Miranda J
Crovetto F
Eixarch E
Rodriguez-Sureda V
Dominguez C
Casu G
Rovira C
Nadal A
Crispi F
Gratacos E
author Paules C
author_facet Paules C
Dantas AP
Miranda J
Crovetto F
Eixarch E
Rodriguez-Sureda V
Dominguez C
Casu G
Rovira C
Nadal A
Crispi F
Gratacos E
author_role author
author2 Dantas AP
Miranda J
Crovetto F
Eixarch E
Rodriguez-Sureda V
Dominguez C
Casu G
Rovira C
Nadal A
Crispi F
Gratacos E
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv aging
apoptosis
fetal growth restriction
placenta
senescence
small-for-gestational age
topic aging
apoptosis
fetal growth restriction
placenta
senescence
small-for-gestational age
description Objective To perform a comprehensive assessment of the placental aging process in small term fetuses classified as being small-for-gestational age (SGA) or having fetal growth restriction (FGR) through analysis of senescence and apoptosis markers. Methods This was a prospective nested case-control study of singleton pregnancies delivered at term, including 21 control pregnancies with normally grown fetuses and 36 with a small fetus classified as SGA (birth weight between the 3rd and 9th percentiles and normal fetoplacental Doppler; n=18) or FGR (birth weight <3rd percentile and/or abnormal cerebroplacental ratio and/or uterine artery Doppler; n=18). Telomerase activity, telomere length (quantified by comparing the amount of amplification product for the telomere sequence (T) to that of a single copy of the gene 36B4 (S)) and RNA expression of senescence (Sirtuins 1, 3 and 6) and apoptosis (p53, p21, BAX and Caspases 3 and 9) markers (analyzed using the 2(-Delta Delta Ct) method) were determined in placental samples collected at birth and compared between the three groups. Results Compared to pregnancies with a normally grown fetus, both SGA and FGR pregnancies presented signs of accelerated placental aging, including lower telomerase activity (mean +/- SD, 12.8 +/- 6.6% in controls vs 7.98 +/- 4.2% in SGA vs 7.79 +/- 4.6% in FGR; P=0.008), shorter telomeres (mean +/- SD T/S ratio, 1.20 +/- 0.6 in controls vs 1.08 +/- 0.9 in SGA vs 0.66 +/- 0.5 in FGR; P=0.047) and reduced Sirtuin-1 RNAexpression (mean +/- SD 2(-Delta Delta Ct), 1.55 +/- 0.8 in controls vs 0.91 +/- 0.8 in SGA vs 0.63 +/- 0.5 in FGR; P=0.001) together with increased p53 RNA expression (median (interquartile range) 2(-Delta Delta Ct), 1.07 (0.3-3.3) in controls vs 5.39 (0.6-15) in SGA vs 3.75 (0.9-7.8) in FGR; P=0.040). FGR cases presented signs of apoptosis, with increased Caspase-3 RNA levels (median (interquartile range) 2(-Delta Delta Ct), 0.94 (0.7-1.7) in controls vs 3.98 (0.9-31) in FGR; P=0.031) and Caspase-9 RNA levels (median (interquartile range) 2(-Delta Delta Ct), 1.21 (0.6-4.0) in controls vs 3.87 (1.5-9.0) in FGR; P= 0.037) compared with controls. In addition, Sirtuin-1 RNA expression, telomerase activity, telomere length and Caspase-3 activity showed significant linear trends across groups as severity of the condition increased. Conclusions Accelerated placental aging was observed in both clinical forms of late-onset fetal smallness (SGA and FGR), supporting a common pathophysiology and challenging the concept of SGA fetuses being constitutionally small. Copyright (c) 2018 ISUOG. Published by John Wiley & Sons Ltd.
publishDate 2019
dc.date.none.fl_str_mv 2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14796
url https://fsjd.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=14796
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv WILEY
publisher.none.fl_str_mv WILEY
dc.source.none.fl_str_mv ULTRASOUND IN OBSTETRICS & GYNECOLOGY
ISSN: 09607692
ISSNe: 14690705
reponame:r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname:Fundació Sant Joan de Déu
instname_str Fundació Sant Joan de Déu
reponame_str r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
collection r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869404430165606400
score 15,811543

Similares en LA Referencia